Oral 2-hydroxyoleic acid inhibits reflex hypersensitivity and open-field-induced anxiety after spared nerve injury

European Journal of Pain (United Kingdom)

Volumn 19, Issue 1, 2015, Pages 111-122

  Avila Martin, G ^a   Galan Arriero, I ^a   Ferrer Donato, A ^a   Busquets, X ^b   Gomez Soriano, J ^a,c   Escriba P V ^b   Taylor, Julian ^a  

^a HOSPITAL NACIONAL DE PARAPLÉJICOS   (Spain)

^b UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^c UNIVERSITY OF CASTILLA LA MANCHA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; LIPOPOLYSACCHARIDE; PREGABALIN; RICINOLEIC ACID; 2-HYDROXYOLEIC ACID; OLEIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ANXIETY; ARTICLE; AVERSION; CONTROLLED STUDY; ESCAPE BEHAVIOR; EXPLORATORY BEHAVIOR; HINDLIMB; HYPERSENSITIVITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MACROPHAGE; MALE; MICROGLIA; NERVE INJURY; NEUROMODULATION; NONHUMAN; OPEN FIELD BEHAVIOR; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REFLEX; SCREENING; SHAM PROCEDURE; SPARED NERVE INJURY; SPINAL CORD DORSAL HORN; STIMULATION; VON FREY TEST; WESTERN BLOTTING; ANIMAL; COMPLICATION; DIET THERAPY; DRUG EFFECTS; HYPERALGESIA; METABOLISM; NEURALGIA; ORAL DRUG ADMINISTRATION; PAIN THRESHOLD; PATHOLOGICAL REFLEX; PATHOPHYSIOLOGY; PERIPHERAL NERVE INJURY; WISTAR RAT;

ADMINISTRATION, ORAL; ANIMALS; ANXIETY; HYPERALGESIA; MALE; MICROGLIA; NEURALGIA; OLEIC ACIDS; PAIN THRESHOLD; PERIPHERAL NERVE INJURIES; RATS; RATS, WISTAR; REFLEX, ABNORMAL;

EID: 84923303473     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1002/ejp.528     Document Type: Article

References (70)

1. Alberts, G.L., Chio, C.L., Im, W.B., (2001). Allosteric modulation of the human 5-HT(7A) receptor by lipidic amphipathic compounds. Mol Pharmacol 60, 1349-1355.
2. Aldskogius, H., Kozlova, E.N., (2013). Microglia and neuropathic pain. CNS Neurol Disord Drug Targets 12, 768-772.
3. Alemany, R., Teres, S., Baamonde, C., Benet, M., Vogler, O., Escriba, P.V., (2004). 2-hydroxyoleic acid: A new hypotensive molecule. Hypertension 43, 249-254.
4. Alemany, R., Vogler, O., Teres, S., Egea, C., Baamonde, C., Barcelo, F., Delgado, C., Jakobs, K.H., Escriba, P.V., (2006). Antihypertensive action of 2-hydroxyoleic acid in SHRs via modulation of the protein kinase A pathway and Rho kinase. J Lipid Res 47, 1762-1770.
5. Alvarado, S., Tajerian, M., Millecamps, M., Suderman, M., Stone, L.S., Szyf, M., (2013). Peripheral nerve injury is accompanied by chronic transcriptome-wide changes in the mouse prefrontal cortex. Mol Pain 9, 21.
6. Avila-Martin, G., Galan-Arriero, I., Gomez-Soriano, J., Taylor, J., (2011). Treatment of rat spinal cord injury with the neurotrophic factor albumin-oleic acid: Translational application for paralysis, spasticity and pain. PLoS ONE 6, e26107.
7. Baastrup, C., Maersk-Moller, C.C., Nyengaard, J.R., Jensen, T.S., Finnerup, N.B., (2010). Spinal-, brainstem- and cerebrally mediated responses at- and below-level of a spinal cord contusion in rats: Evaluation of pain-like behavior. Pain 151, 670-679.
8. Borsonelo, E.C., Vieira, L., Galduroz, J.C., (2013). The influence of the polyunsaturated fatty acids on body weight and anxiolytic-like behavior in female rats. Nutr Neurosci 16, 2-5.
9. Braun, A.A., Skelton, M.R., Vorhees, C.V., Williams, M.T., (2011). Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: Effects of anxiolytic and anxiogenic agents. Pharmacol Biochem Behav 97, 406-415.
10. Breivik, H., Collett, B., Ventafridda, V., Cohen, R., Gallacher, D., (2006). Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment. Eur J Pain 10, 287-333.
11. Brenchat, A., Zamanillo, D., Hamon, M., Romero, L., Vela, J.M., (2012). Role of peripheral versus spinal 5-HT(7) receptors in the modulation of pain undersensitizing conditions. Eur J Pain 16, 72-81.
12. Chan, P.H., Chu, L., Fishman, R.A., (1988). Reduction of activities of superoxide dismutase but not of glutathione peroxidase in rat brain regions following decapitation ischemia. Brain Res 439, 388-390.
13. Chaplan, S.R., Bach, F.W., Pogrel, J.W., Chung, J.M., Yaksh, T.L., (1994). Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53, 55-63.
14. Churi, S.B., Abdel-Aleem, O.S., Tumber, K.K., Scuderi-Porter, H., Taylor, B.K., (2008). Intrathecal rosiglitazone acts at peroxisome proliferator-activated receptor-gamma to rapidly inhibit neuropathic pain in rats. J Pain 9, 639-649.
15. Contreras, C.M., Rodriguez-Landa, J.F., Gutierrez-Garcia, A.G., Mendoza-Lopez, M.R., Garcia-Rios, R.I., Cueto-Escobedo, J., (2011). Anxiolytic-like effects of human amniotic fluid and its fatty acids in Wistar rats. Behav Pharmacol 22, 655-662.
16. Decosterd, I., Allchorne, A., Woolf, C.J., (2004). Differential analgesic sensitivity of two distinct neuropathic pain models. Anesth Analg 99, 457-463.
17. Decosterd, I., Woolf, C.J., (2000). Spared nerve injury: An animal model of persistent peripheral neuropathic pain. Pain 87, 149-158.
18. Dixon, W.J., (1980). Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20, 441-462.
19. Durrenberger, P.F., Facer, P., Casula, M.A., Yiangou, Y., Gray, R.A., Chessell, I.P., Day, N.C., Collins, S.D., Bingham, S., Wilson, A.W., Elliot, D., Birch, R., Anand, P., (2006). Prostanoid receptor EP1 and Cox-2 in injured human nerves and a rat model of nerve injury: A time-course study. BMC Neurol 6, 1.
20. Durrenberger, P.F., Facer, P., Gray, R.A., Chessell, I.P., Naylor, A., Bountra, C., Banati, R.B., Birch, R., Anand, P., (2004). Cyclooxygenase-2 (COX-2) in injured human nerve and a rat model of nerve injury. J Peripher Nerv Syst 9, 15-25.
21. Erichsen, H.K., Blackburn-Munro, G., (2002). Pharmacological characterisation of the spared nerve injury model of neuropathic pain. Pain 98, 151-161.
22. Fandel, D., Wasmuht, D., Avila-Martin, G., Taylor, J.S., Galan-Arriero, I., Mey, J., (2013). Spinal cord injury induced changes of nuclear receptors PPARα and LXRβ and modulation with oleic acid/albumin treatment. Brain Res 1535, 89-105.
23. Fedorova, I., Hashimoto, A., Fecik, R.A., Hedrick, M.P., Hanus, L.O., Boger, D.L., Rice, K.C., Basile, A.S., (2001). Behavioral evidence for the interaction of oleamide with multiple neurotransmitter systems. J Pharmacol Exp Ther 299, 332-342.
24. Fehrenbacher, J.C., Loverme, J., Clarke, W., Hargreaves, K.M., Piomelli, D., Taylor, B.K., (2009). Rapid pain modulation with nuclear receptor ligands. Brain Res Rev 60, 114-124.
25. Gregoire, S., Michaud, V., Chapuy, E., Eschalier, A., Ardid, D., (2012). Study of emotional and cognitive impairments in mononeuropathic rats: Effect of duloxetine and gabapentin. Pain 153, 1657-1663.
26. Gustafsson, H., Sandin, J., (2009). Oral pregabalin reverses cold allodynia in two distinct models of peripheral neuropathic pain. Eur J Pharmacol 605, 103-108.
27. Guzman, M., Lo Verme, J., Fu, J., Oveisi, F., Blazquez, C., Piomelli, D., (2004). Oleoylethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor alpha (PPAR-alpha). J Biol Chem 279, 27849-27854.
28. Hart, C.M., Tolson, J.K., Block, E.R., (1991). Supplemental fatty acids alter lipid peroxidation and oxidant injury in endothelial cells. Am J Physiol 260, L481-L488.
29. Ho, Y.J., Eichendorff, J., Schwarting, R.K., (2002). Individual response profiles of male Wistar rats in animal models for anxiety and depression. Behav Brain Res 136, 1-12.
30. James, M.J., Gibson, R.A., Neumann, M.A., Cleland, L.G., (1993). Effect of dietary supplementation with n-9 eicosatrienoic acid on leukotriene B4 synthesis in rats: A novel approach to inhibition of eicosanoid synthesis. J Exp Med 178, 2261-2265.
31. Ji, R.R., Berta, T., Nedergaard, M., (2013). Glia and pain: Is chronic pain a gliopathy? Pain 154 (Suppl. 1), S10-28.
32. Johansen, J.P., Fields, H.L., Manning, B.H., (2001). The affective component of pain in rodents: Direct evidence for a contribution of the anterior cingulate cortex. Proc Natl Acad Sci U S A 98, 8077-8082.
33. Kanda, H., Kobayashi, K., Yamanaka, H., Noguchi, K., (2013). COX-1-dependent prostaglandin D2 in microglia contributes to neuropathic pain via DP2 receptor in spinal neurons. Glia 61, 943-956.
34. King, T., Vera-Portocarrero, L., Gutierrez, T., Vanderah, T.W., Dussor, G., Lai, J., Fields, H.L., Porreca, F., (2009). Unmasking the tonic-aversive state in neuropathic pain. Nat Neurosci 12, 1364-1366.
35. Kremer, J.M., Lawrence, D.A., Jubiz, W., DiGiacomo, R., Rynes, R., Bartholomew, L.E., Sherman, M., (1990). Dietary fish oil and olive oil supplementation in patients with rheumatoid arthritis. Clinical and immunologic effects. Arthritis Rheum 33, 810-820.
36. LaBuda, C.J., Fuchs, P.N., (2000a). A behavioral test paradigm to measure the aversive quality of inflammatory and neuropathic pain in rats. Exp Neurol 163, 490-494.
37. LaBuda, C.J., Fuchs, P.N., (2000b). Morphine and gabapentin decrease mechanical hyperalgesia and escape/avoidance behavior in a rat model of neuropathic pain. Neurosci Lett 290, 137-140.
38. Lavado, E., Sanchez-Abarca, L.I., Tabernero, A., Bolanos, J.P., Medina, J.M., (1997). Oleic acid inhibits gap junction permeability and increases glucose uptake in cultured rat astrocytes. J Neurochem 69, 721-728.
39. Lee, K.M., Jeon, S.M., Cho, H.J., (2010). Interleukin-6 induces microglial CX3CR1 expression in the spinal cord after peripheral nerve injury through the activation of p38 MAPK. Eur J Pain 14, 682.e1-682.e12.
40. LoVerme, J., Russo, R., La Rana, G., Fu, J., Farthing, J., Mattace-Raso, G., Meli, R., Hohmann, A., Calignano, A., Piomelli, D., (2006). Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor-alpha. J Pharmacol Exp Ther 319, 1051-1061.
41. Martinez, J., Vogler, O., Casas, J., Barcelo, F., Alemany, R., Prades, J., Nagy, T., Baamonde, C., Kasprzyk, P.G., Teres, S., Saus, C., Escriba, P.V., (2005). Membrane structure modulation, protein kinase C alpha activation, and anticancer activity of minerval. Mol Pharmacol 67, 531-540.
42. Matsui, T., Svensson, C.I., Hirata, Y., Mizobata, K., Hua, X.Y., Yaksh, T.L., (2010). Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase. Anesth Analg 111, 554-560.
43. Matsuo, M., Hamasaki, Y., Fujiyama, F., Miyazaki, S., (1995). Eicosanoids are produced by microglia, not by astrocytes, in rat glial cell cultures. Brain Res 685, 201-204.
44. McCracken, L.M., Faber, S.D., Janeck, A.S., (1998). Pain-related anxiety predicts non-specific physical complaints in persons with chronic pain. Behav Res Ther 36, 621-630.
45. Milligan, E.D., Watkins, L.R., (2009). Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 10, 23-36.
46. Morgenweck, J., Griggs, R.B., Donahue, R.R., Zadina, J.E., Taylor, B.K., (2013). PPARgamma activation blocks development and reduces established neuropathic pain in rats. Neuropharmacology 70, 236-246.
47. Oh, Y.T., Lee, J.Y., Lee, J., Lee, J.H., Kim, J.E., Ha, J., Kang, I., (2010). Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF-kappaB activation in BV2 murine microglial cells. Neurosci Lett 474, 148-153.
48. Okubo, M., Yamanaka, H., Kobayashi, K., Noguchi, K., (2010). Leukotriene synthases and the receptors induced by peripheral nerve injury in the spinal cord contribute to the generation of neuropathic pain. Glia 58, 599-610.
49. Pedersen, L.H., Blackburn-Munro, G., (2006). Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain. Psychopharmacology (Berl) 185, 208-217.
50. Perez, C., Navarro, A., Saldana, M.T., Masramon, X., Rejas, J., (2010). Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study. Clin Ther 32, 1357-1370.
51. Pertin, M., Allchorne, A.J., Beggah, A.T., Woolf, C.J., Decosterd, I., (2007). Delayed sympathetic dependence in the spared nerve injury (SNI) model of neuropathic pain. Mol Pain 3, 21.
52. Pradhan, A.A., Yu, X.H., Laird, J.M., (2010). Modality of hyperalgesia tested, not type of nerve damage, predicts pharmacological sensitivity in rat models of neuropathic pain. Eur J Pain 14, 503-509.
53. Rahman, W., Suzuki, R., Webber, M., Hunt, S.P., Dickenson, A.H., (2006). Depletion of endogenous spinal 5-HT attenuates the behavioural hypersensitivity to mechanical and cooling stimuli induced by spinal nerve ligation. Pain 123, 264-274.
54. Rode, F., Jensen, D.G., Blackburn-Munro, G., Bjerrum, O.J., (2005). Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain. Eur J Pharmacol 516, 131-138.
55. Schmid, A.B., Coppieters, M.W., Ruitenberg, M.J., McLachlan, E.M., (2013). Local and remote immune-mediated inflammation after mild peripheral nerve compression in rats. J Neuropathol Exp Neurol 72, 662-680.
56. Scholz, J., Abele, A., Marian, C., Haussler, A., Herbert, T.A., Woolf, C.J., Tegeder, I., (2008). Low-dose methotrexate reduces peripheral nerve injury-evoked spinal microglial activation and neuropathic pain behavior in rats. Pain 138, 130-142.
57. Scholz, J., Woolf, C.J., (2007). The neuropathic pain triad: Neurons, immune cells and glia. Nat Neurosci 10, 1361-1368.
58. Seminowicz, D.A., Laferriere, A.L., Millecamps, M., Yu, J.S., Coderre, T.J., Bushnell, M.C., (2009). MRI structural brain changes associated with sensory and emotional function in a rat model of long-term neuropathic pain. Neuroimage 47, 1007-1014.
59. Troeger, M.B., Wilson, D.F., Erecinska, M., (1984). The effect of thiol reagents on GABA transport in rat brain synaptosomes. FEBS Lett 171, 303-308.
60. Ultenius, C., Linderoth, B., Meyerson, B.A., Wallin, J., (2006). Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat. Neurosci Lett 399, 85-90.
61. van Seventer, R., Bach, F.W., Toth, C.C., Serpell, M., Temple, J., Murphy, T.K., Nimour, M., (2010). Pregabalin in the treatment of post-traumatic peripheral neuropathic pain: A randomized double-blind trial. Eur J Neurol 17, 1082-1089.
62. Vahidy, W.H., Ong, W.Y., Farooqui, A.A., Yeo, J.F., (2006). Effects of intracerebroventricular injections of free fatty acids, lysophospholipids, or platelet activating factor in a mouse model of orofacial pain. Exp Brain Res 174, 781-785.
63. Vissers, K.C., De Jongh, R.F., Hoffmann, V.L., Meert, T.F., (2005). Exogenous interleukin-6 increases cold allodynia in rats with a mononeuropathy. Cytokine 30, 154-159.
64. Vogler, O., Lopez-Bellan, A., Alemany, R., Tofe, S., Gonzalez, M., Quevedo, J., Pereg, V., Barcelo, F., Escriba, P.V., (2008). Structure-effect relation of C18 long-chain fatty acids in the reduction of body weight in rats. Int J Obes (Lond) 32, 464-473.
65. Wagner, R., Heckman, H.M., Myers, R.R., (1998). Wallerian degeneration and hyperalgesia after peripheral nerve injury are glutathione-dependent. Pain 77, 173-179.
66. Wang, H., Cao, Y., Chiang, C.Y., Dostrovsky, J.O., Sessle, B.J., (2014). The gap junction blocker carbenoxolone attenuates nociceptive behavior and medullary dorsal horn central sensitization induced by partial infraorbital nerve transection in rats. Pain 155, 429-435.
67. Yang, F., Whang, J., Derry, W.T., Vardeh, D., Scholz, J., (2014). Analgesic treatment with pregabalin does not prevent persistent pain after peripheral nerve injury in the rat. Pain 155, 356-366.
68. Zhang, X., Koronowski, K.B., Li, L., Freeman, B.A., Woodcock, S., de Groat, W.C., (2014). Nitro-oleic acid desensitizes TRPA1 and TRPV1 agonist responses in adult rat DRG neurons. Exp Neurol 251, 12-21.
69. Zhuang, Z.Y., Kawasaki, Y., Tan, P.H., Wen, Y.R., Huang, J., Ji, R.R., (2007). Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine. Brain Behav Immun 21, 642-651.
70. Zimmermann, M., (1983). Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16, 109-110.